| Product NDC: | 0536-4301 |
| Proprietary Name: | Bismuth subsalicylate |
| Non Proprietary Name: | Bismuth subsalicylate |
| Active Ingredient(s): | 262 mg/1 & nbsp; Bismuth subsalicylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0536-4301 |
| Labeler Name: | Rugby Laboratories Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part335 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 19960123 |
| Package NDC: | 0536-4301-07 |
| Package Description: | 30 TABLET in 1 BOTTLE (0536-4301-07) |
| NDC Code | 0536-4301-07 |
| Proprietary Name | Bismuth subsalicylate |
| Package Description | 30 TABLET in 1 BOTTLE (0536-4301-07) |
| Product NDC | 0536-4301 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Bismuth subsalicylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19960123 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Rugby Laboratories Inc. |
| Substance Name | BISMUTH SUBSALICYLATE |
| Strength Number | 262 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |